Retraction: MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells (PLoS ONE (2011) 6:6 (e20614) DOI: 10.1371/journal.pone.0020614);MMP-2 siRNA inhibits radiation-enhanced invasiveness in glioma cells

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Badiga, Aruna Venkata ^a   Chetty, Chandramu ^a   Kesanakurti, Divya ^a   Are, Deepthi ^a   Gujrati, Meena ^a   Klopfenstein, Jeffrey D ^a   Dinh, Dzung H ^a   Rao, Jasti S ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOCAL ADHESION KINASE; GELATINASE A; PLASMID VECTOR; SMALL INTERFERING RNA; SYNAPTOPHYSIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME INHIBITION; EXPRESSION VECTOR; GENETIC TRANSFECTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; MIGRATION INHIBITION; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PROTEIN TARGETING; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING; BRAIN TUMOR; GENETICS; GLIOMA; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PLASMID; TUMOR CELL LINE; VASCULARIZATION;

ANIMALIA;

BLOTTING, WESTERN; BRAIN NEOPLASMS; CELL LINE, TUMOR; GLIOMA; HUMANS; MATRIX METALLOPROTEINASE 2; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PLASMIDS; RADIATION, IONIZING; RNA, SMALL INTERFERING;

EID: 79959187557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0228689     Document Type: Erratum

References (56)

1. Holland EC, (2001) Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2: 120-129.
2. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, et al. (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-1333.
3. Zhu Y, Parada LF, (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2: 616-626.
4. Giese A, Westphal M, (1996) Glioma invasion in the central nervous system. Neurosurgery 39: 235-250.
5. Kleihues P, Cavenee WK, (2000) Pathology and Genetics of Tumours of the Central Nervous System. In: Kleihues P, Cavenee WK, editors. World Heath Organization Classification of Tumours. Lyon, IARC.
6. Coussens LM, Werb Z, (1996) Matrix metalloproteinases and the development of cancer. Chem Biol 3: 895-904.
7. Rao JS, (2003) Molecular mechanisms of glioma invasiveness: the role of proteases. Nat Rev Cancer 3: 489-501.
8. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, et al. (2002) Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res 8: 2894-2901.
9. Egeblad M, Werb Z, (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
10. Forsyth PA, Wong H, Laing TD, Rewcastle NB, Morris DG, et al. (1999) Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br J Cancer 79: 1828-1835.
11. Jiang Y, Goldberg ID, Shi YE, (2002) Complex roles of tissue inhibitors of metalloproteinases in cancer. Oncogene 21: 2245-2252.
12. Taghian A, DuBois W, Budach W, Baumann M, Freeman J, et al. (1995) In vivo radiation sensitivity of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 32: 99-104.
13. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W, (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750.
14. Cheng JC, Chou CH, Kuo ML, Hsieh CY, (2006) Radiation-enhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25: 7009-7018.
15. Park JS, Qiao L, Su ZZ, Hinman D, Willoughby K, et al. (2001) Ionizing radiation modulates vascular endothelial growth factor (VEGF) expression through multiple mitogen activated protein kinase dependent pathways. Oncogene 20: 3266-3280.
16. Wang JL, Sun Y, Wu S, (2000) Gamma-irradiation induces matrix metalloproteinase II expression in a p53-dependent manner. Mol Carcinog 27: 252-258.
17. Araya J, Maruyama M, Sassa K, Fujita T, Hayashi R, et al. (2001) Ionizing radiation enhances matrix metalloproteinase-2 production in human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 280: L30-L38.
18. Camphausen K, Moses MA, Beecken WD, Khan MK, Folkman J, et al. (2001) Radiation therapy to a primary tumor accelerates metastatic growth in mice. Cancer Res 61: 2207-2211.
19. Qian LW, Mizumoto K, Urashima T, Nagai E, Maehara N, et al. (2002) Radiation-induced increase in invasive potential of human pancreatic cancer cells and its blockade by a matrix metalloproteinase inhibitor, CGS27023. Clin Cancer Res 8: 1223-1227.
20. Sawaya R, Tofilon PJ, Mohanam S, Ali-Osman F, Liotta LA, et al. (1994) Induction of tissue-type plasminogen activator and 72-kDa type-IV collagenase by ionizing radiation in rat astrocytes. Int J Cancer 56: 214-218.
21. Wei J, Zhou S, Bachem MG, Debatin KM, Beltinger C, (2007) Infiltration of blood outgrowth endothelial cells into tumor spheroids: role of matrix metalloproteinases and irradiation. Anticancer Res 27: 1415-1421.
22. Zhao W, O'Malley Y, Robbins ME, (1999) Irradiation of rat mesangial cells alters the expression of gene products associated with the development of renal fibrosis. Radiat Res 152: 160-169.
23. Zhao W, O'Malley Y, Wei S, Robbins ME, (2000) Irradiation of rat tubule epithelial cells alters the expression of gene products associated with the synthesis and degradation of extracellular matrix. Int J Radiat Biol 76: 391-402.
24. Coussens LM, Fingleton B, Matrisian LM, (2002) Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
25. Folgueras AR, Pendas AM, Sanchez LM, Lopez-Otin C, (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48: 411-424.
26. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, et al. (2002) RNA interference in adult mice. Nature 418: 38-39.
27. Chetty C, Bhoopathi P, Joseph P, Chittivelu S, Rao JS, et al. (2006) Adenovirus-mediated siRNA against MMP-2 suppresses tumor growth and lung metastasis in mice. Mol Cancer Ther 5: 2289-2299.
28. Chetty C, Bhoopathi P, Rao JS, Lakka SS, (2009) Inhibition of matrix metalloproteinase-2 enhances radiosensitivity by abrogating radiation-induced FoxM1-mediated G2/M arrest in A549 lung cancer cells. Int J Cancer 124: 2468-2477.
29. Chetty C, Bhoopathi P, Lakka SS, Rao JS, (2007) MMP-2 siRNA induced Fas/CD95-mediated extrinsic II apoptotic pathway in the A549 lung adenocarcinoma cell line. Oncogene 26: 7675-7683.
30. Tyler MA, Sonabend AM, Ulasov IV, Lesniak MS, (2008) Vector therapies for malignant glioma: shifting the clinical paradigm. Expert Opin Drug Deliv 5: 445-458.
31. Chintala SK, Sawaya R, Gokaslan ZL, Rao JS, (1996) Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. Cancer Lett 103: 201-208.
32. Silletti S, Kessler T, Goldberg J, Boger DL, Cheresh DA, (2001) Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc Natl Acad Sci USA 98: 119-124.
33. Tonn JC, Kerkau S, Hanke A, Bouterfa H, Mueller JG, et al. (1999) Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro. Int J Cancer 80: 764-772.
34. Wick W, Wick A, Schulz JB, Dichgans J, Rodemann HP, et al. (2002) Prevention of irradiation-induced glioma cell invasion by temozolomide involves caspase 3 activity and cleavage of focal adhesion kinase. Cancer Res 62: 1915-1919.
35. Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, et al. (2000) Selective suppression of matrix metalloproteinase-9 in human glioblastoma cells by antisense gene transfer impairs glioblastoma cell invasion. Cancer Res 60: 6851-6855.
36. Lakka SS, Rajan M, Gondi CS, Yanamandra N, Chandrasekar N, et al. (2002) Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion. Oncogene 21: 8011-8019.
37. Gridley DS, Loredo LN, Slater JD, Archambeau JO, Bedros AA, et al. (1998) Pilot evaluation of cytokine levels in patients undergoing radiotherapy for brain tumor. Cancer Detect Prev 22: 20-29.
38. Gorski DH, Beckett MA, Jaskowiak NT, Calvin DP, Mauceri HJ, et al. (1999) Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res 59: 3374-3378.
39. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, et al. (2003) Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 300: 1155-1159.
40. Sartor CI, (2004) Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors. Nat Clin Pract Oncol 1: 80-87.
41. Senan S, Smit EF, (2007) Design of clinical trials of radiation combined with antiangiogenic therapy. Oncologist 12: 465-477.
42. Belotti D, Paganoni P, Manenti L, Garofalo A, Marchini S, et al. (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63: 5224-5229.
43. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-744.
44. Manenti L, Paganoni P, Floriani I, Landoni F, Torri V, et al. (2003) Expression levels of vascular endothelial growth factor, matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 and 2 in the plasma of patients with ovarian carcinoma. Eur J Cancer 39: 1948-1956.
45. Kaliski A, Maggiorella L, Cengel KA, Mathe D, Rouffiac V, et al. (2005) Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Mol Cancer Ther 4: 1717-1728.
46. Hovinga KE, Stalpers LJ, van Bree C, Donker M, Verhoeff JJ, et al. (2005) Radiation-enhanced vascular endothelial growth factor (VEGF) secretion in glioblastoma multiforme cell lines-a clue to radioresistance? J Neurooncol 74: 99-103.
47. Podar K, Anderson KC, (2007) Inhibition of VEGF signaling pathways in multiple myeloma and other malignancies. Cell Cycle 6: 538-542.
48. Katoh O, Tauchi H, Kawaishi K, Kimura A, Satow Y, (1995) Expression of the vascular endothelial growth factor (VEGF) receptor gene, KDR, in hematopoietic cells and inhibitory effect of VEGF on apoptotic cell death caused by ionizing radiation. Cancer Res 55: 5687-5692.
49. Katoh O, Takahashi T, Oguri T, Kuramoto K, Mihara K, et al. (1998) Vascular endothelial growth factor inhibits apoptotic death in hematopoietic cells after exposure to chemotherapeutic drugs by inducing MCL1 acting as an antiapoptotic factor. Cancer Res 58: 5565-5569.
50. Pidgeon GP, Barr MP, Harmey JH, Foley DA, Bouchier-Hayes DJ, (2001) Vascular endothelial growth factor (VEGF) upregulates BCL-2 and inhibits apoptosis in human and murine mammary adenocarcinoma cells. Br J Cancer 85: 273-278.
51. Haas-Kogan DA, Yount G, Haas M, Levi D, Kogan SS, et al. (1996) p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int J Radiat Oncol Biol Phys 36: 95-103.
52. Haas-Kogan DA, Dazin P, Hu L, Deen DF, Israel A, (1996) P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells. Cancer J Sci Am 2: 114-121.
53. Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W, (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61 (6): 2744-2750.
54. Prise KM, Schettino G, Folkard M, Held KD, (2005) New insights on cell death from radiation exposure. Lancet Oncol 6 (7): 520-528.
55. Sawaya R, Go Y, Kyritsis AP, Uhm J, Venkaiah B, et al. (1998) Elevated levels of Mr 92,000 type IV collagenase during tumor growth in vivo. Biochem Biophys Res Commun 251: 632-636.
56. Engelhorn T, Savaskan NE, Schwarz MA, Kreutzer J, Meyer EP, et al. (2009) Cellular characterization of the peritumoral edema zone in malignant brain tumors. Cancer Sci 100: 1856-1862.